Keyword: Novo Nordisk

News

US Top Court Rules for Generic Drugmaker on Patent

18.04.2012 - The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to...

News

EU Agency Issues Guideline on Biosimilar MS Drugs

24.01.2012 - European regulators took another step towards opening the market for copies of biotech drugs on by releasing a draft guideline on how companies should test biosimilar medicines...

News

Novo CEO Lars Sorensen: China Drug Sales Set To Bounce Back

06.12.2011 - Sales to China by Denmark's Novo Nordisk, the world's biggest supplier of insulin, are set to bounce back after a one-off fall in the third quarter, the Danish drugmaker's chief...

News

Russia Set for More Inward Pharma Investment

10.02.2011 - More global drugmakers will soon announce plans to establish a local presence in Russia in response to government measures to boost its domestic sector and cut dependence on...

Plant Construction & Process Technology

Pharma Sourcing from India and China

26.01.2011 - India and China are being discovered by more companies as ideal place for pharma sourcing. These two countries continue to be the chosen destinations for a pharmaceutical industry...

News

Anne Phillips Appointed VP of Novo Nordisk's Clinical Development, Medical and Regulatory Affairs for North America

04.01.2011 - Anne Phillips, M.D., has been appointed as Novo Nordisk's as vice president, Clinical Development, Medical and Regulatory Affairs for North America. Dr. Phillips reports directly...

News

Putin Warns Of Measures Against Global Drug Firms

09.12.2010 - Pharmaceutical companies and medical equipment makers will face restrictions in Russia if they fail to develop local production and transfer technology, Russian Prime Minister...

News

Novo's new Insulin Less Variable than Sanofi Rival

22.09.2010 - Novo Nordisk's experimental ultra-long-acting insulin degludec is up to four times less variable in its day-to-day effect than Sanofi-Aventis's established rival Lantus, data on...